Not Tagged
Not Tagged
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'tianjin', 'novo ']
#ash22 #leusm zhang: clinical application of flow based mrd (mfc-mrd) in de novo aml. n=769 achieving cr evaluated by mfc-mrd. 15% eln adv risk, 55% favorable (high). 3yr os 70% in this cohort (high). 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)